Description
Roger Pharma RETADRELINE (Retatrutide) is a peptide formulation containing Retatrutide, a novel multi-receptor agonist widely studied for its interaction with GLP-1, GIP, and glucagon receptors. It is commonly researched for its potential role in metabolic regulation, body weight management, glucose metabolism, and energy balance.
Each pack contains 2 vials, with 6 mg of Retatrutide per vial, providing a total peptide content of 12 mg. Roger Pharma RETADRELINE is supplied in a lyophilized format and is intended for research applications involving peptide science, metabolic biology, and endocrinology studies.
Key Features
- Retatrutide peptide formulation
- 6 mg per vial
- 2 vials per pack
- Total peptide content: 12 mg
- Lyophilized peptide format
- Studied for GLP-1, GIP, and glucagon receptor pathways
- Research-focused peptide compound
Contents
- Active Ingredient: Retatrutide – 6 mg
- Quantity: 2 Vials
Reviews
There are no reviews yet.